445 related articles for article (PubMed ID: 30254634)
1. NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy.
Schmiedel D; Mandelboim O
Front Immunol; 2018; 9():2040. PubMed ID: 30254634
[TBL] [Abstract][Full Text] [Related]
2. Natural killer group 2D receptor and its ligands in cancer immune escape.
Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
[TBL] [Abstract][Full Text] [Related]
3. Leveraging NKG2D Ligands in Immuno-Oncology.
Fuertes MB; Domaica CI; Zwirner NW
Front Immunol; 2021; 12():713158. PubMed ID: 34394116
[TBL] [Abstract][Full Text] [Related]
4. The NKG2D axis: an emerging target in cancer immunotherapy.
Lazarova M; Steinle A
Expert Opin Ther Targets; 2019 Apr; 23(4):281-294. PubMed ID: 30732494
[TBL] [Abstract][Full Text] [Related]
5. Arming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D-ligand system.
Lazarova M; Wels WS; Steinle A
Expert Opin Biol Ther; 2020 Dec; 20(12):1491-1501. PubMed ID: 32726145
[TBL] [Abstract][Full Text] [Related]
6. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D
Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194
[TBL] [Abstract][Full Text] [Related]
7. Differential Effects of Histone Deacetylases on the Expression of NKG2D Ligands and NK Cell-Mediated Anticancer Immunity in Lung Cancer Cells.
Cho H; Son WC; Lee YS; Youn EJ; Kang CD; Park YS; Bae J
Molecules; 2021 Jun; 26(13):. PubMed ID: 34203519
[TBL] [Abstract][Full Text] [Related]
8. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
9. Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.
El-Gazzar A; Groh V; Spies T
J Immunol; 2013 Aug; 191(4):1509-15. PubMed ID: 23913973
[TBL] [Abstract][Full Text] [Related]
10. Targeting NKG2D in tumor surveillance.
Hayakawa Y
Expert Opin Ther Targets; 2012 Jun; 16(6):587-99. PubMed ID: 22530569
[TBL] [Abstract][Full Text] [Related]
11. Post-translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention.
Molfetta R; Zingoni A; Santoni A; Paolini R
Front Immunol; 2019; 10():2557. PubMed ID: 31736972
[TBL] [Abstract][Full Text] [Related]
12. Advances in NKG2D ligand recognition and responses by NK cells.
Le Bert N; Gasser S
Immunol Cell Biol; 2014 Mar; 92(3):230-6. PubMed ID: 24445601
[TBL] [Abstract][Full Text] [Related]
13. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
[TBL] [Abstract][Full Text] [Related]
14. Expression of stress ligands of the immunoreceptor NKG2D in melanoma: regulation and clinical significance.
Paschen A; Baingo J; Schadendorf D
Eur J Cell Biol; 2014; 93(1-2):49-54. PubMed ID: 24629838
[TBL] [Abstract][Full Text] [Related]
15. Impairment of NKG2D-Mediated Tumor Immunity by TGF-β.
Lazarova M; Steinle A
Front Immunol; 2019; 10():2689. PubMed ID: 31803194
[TBL] [Abstract][Full Text] [Related]
16. NKG2D signaling in cancer immunosurveillance.
López-Soto A; Huergo-Zapico L; Acebes-Huerta A; Villa-Alvarez M; Gonzalez S
Int J Cancer; 2015 Apr; 136(8):1741-50. PubMed ID: 24615398
[TBL] [Abstract][Full Text] [Related]
17. NKG2D ligands as therapeutic targets.
Spear P; Wu MR; Sentman ML; Sentman CL
Cancer Immun; 2013; 13():8. PubMed ID: 23833565
[TBL] [Abstract][Full Text] [Related]
18. NKG2D ligands in tumor immunity.
Nausch N; Cerwenka A
Oncogene; 2008 Oct; 27(45):5944-58. PubMed ID: 18836475
[TBL] [Abstract][Full Text] [Related]
19. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
Stojanovic A; Correia MP; Cerwenka A
Front Immunol; 2018; 9():827. PubMed ID: 29740438
[TBL] [Abstract][Full Text] [Related]
20. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]